Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cardiol Therapeutics Inc (CRDL.TO)

Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Stocks in play: Cardiol Therapeutics Inc

Announced the data from its Phase II open-label MAvERIC-Pilot study investigating the impact of CardiolRxâ„¢ ...

CRDL.TO : 3.00 (-0.33%)
Cardiol Therapeutics Announces Completion of the MAvERIC Phase II Study in Recurrent Pericarditis with Results to be Presented at the American Heart Association Scientific Sessions 2024

Full clinical data will be reported in an oral presentation at the premier global event for advancements in cardiovascular science and medicine on November 18, 2024Toronto, Ontario--(Newsfile Corp. - September...

CRDL : 2.25 (+2.27%)
CRDL.TO : 3.00 (-0.33%)
Cardiol Therapeutics Reports Results of 2024 Annual General and Special Meeting of Shareholders

Toronto, Ontario--(Newsfile Corp. - June 27, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and...

CRDL : 2.25 (+2.27%)
CRDL.TO : 3.00 (-0.33%)
Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting of Shareholders on June 26th at 4:30 p.m. EDT

Toronto, Ontario--(Newsfile Corp. - June 25, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and...

CRDL : 2.25 (+2.27%)
CRDL.TO : 3.00 (-0.33%)
Stocks in play: Cardiol Therapeutics Inc.

Added another feather to its cap last week with the announcement of its Phase II MAvERIC-Pilot study ...

CRDL.TO : 3.00 (-0.33%)
Cardiol Therapeutics Announces Positive Topline Data from its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis

Administration of CardiolRxâ„¢ led to a marked reduction in the primary efficacy endpoint of pericarditis painCardiolRxâ„¢ also shown to reduce inflammation in patients with elevated CRP89% of patients...

CRDL : 2.25 (+2.27%)
CRDL.TO : 3.00 (-0.33%)
Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024

Scope of presentation included trial design, rationale, and blinded baseline data on first 50 patients randomized into the Phase II study evaluating CardiolRxâ„¢ in patients with acute myocarditis ARCHER...

CRDL : 2.25 (+2.27%)
CRDL.TO : 3.00 (-0.33%)
Manufacturing, Housing Due Next Week in Canada

Monday U.S. Featured Earnings Legend Biotech Corporation (NASDAQ: LEGN) (Q1) EPS ...

CRDL.TO : 3.00 (-0.33%)
ORE.TO : 0.76 (+1.33%)
PBH.TO : 94.65 (+0.98%)
LEGN : 50.83 (+1.84%)
STNE : 12.35 (+0.49%)
PHVS : 21.09 (+4.10%)
BABA : 88.49 (+4.82%)
SONY : 93.23 (+3.03%)
CSCO : 51.44 (+1.72%)
TJX : 118.29 (+0.89%)
CPRT : 51.80 (+1.57%)
WMT : 78.04 (-1.25%)
How a Recent M&A Deal Could Catapult a Small-Cap Biotech to New Heights

Cardiol Therapeutics (CRDL), a clinical-stage life sciences company, is researching and developing new drugs to fight inflammation and scarring in the heart. Their main drug, CardiolRxâ„¢, is b

NVO : 134.88 (+2.14%)
CRDL : 2.25 (+2.27%)
CRDL.TO : 3.00 (-0.33%)
Cardiol Therapeutics Announces Year-End 2023 Update on Operations

Completed patient enrollment in the Phase II MAvERIC-Pilot study evaluating CardiolRxâ„¢ in patients withrecurrent pericarditis, with topline results expected in Q2 2024CardiolRxâ„¢ granted U.S. FDA Orphan...

CRDL : 2.25 (+2.27%)
CRDL.TO : 3.00 (-0.33%)

Barchart Exclusives

1 Bitcoin Stock to Buy and Hold for Long-Term AI Upside
Iris Energy offers prime investment potential in the Bitcoin industry backed by AI investments, record sales, and bullish analyst ratings. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar